Home › Compare › NVRO vs SBUX

NVRO vs SBUX: Dividend Comparison 2026

NVRO yields 34.25% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NVRO wins by $1.6K in total portfolio value
10 years
NVRO
NVRO
● Live price
34.25%
Share price
$5.84
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$168.6K
Annual income
$25,000.88
Full NVRO calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — NVRO vs SBUX

📍 NVRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNVROSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NVRO + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NVRO pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NVRO
Annual income on $10K today (after 15% tax)
$2,910.96/yr
After 10yr DRIP, annual income (after tax)
$21,250.75/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, SBUX beats the other by $39,215.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NVRO + SBUX for your $10,000?

NVRO: 50%SBUX: 50%
100% SBUX50/50100% NVRO
Portfolio after 10yr
$167.8K
Annual income
$48,068.67/yr
Blended yield
28.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

NVRO
Analyst Ratings
9
Buy
19
Hold
4
Sell
Consensus: Hold
Price Target
$30.32
+419.2% upside vs current
Range: $4.00 — $125.00
Altman Z
-0.6
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NVRO buys
0
SBUX buys
0
No recent congressional trades found for NVRO or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNVROSBUX
Forward yield34.25% ✓2.84%
Annual dividend / share$2.00$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3% ✓
Portfolio after 10y$168.6K ✓$167.0K
Annual income after 10y$25,000.88$71,136.45 ✓
Total dividends collected$120.7K$136.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy
Analyst price target$30.32$104.00 ✓

Year-by-year: NVRO vs SBUX ($10,000, DRIP)

YearNVRO PortfolioNVRO Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$14,125$3,424.66$11,121$420.68+$3.0K → NVRO
2$19,634$4,520.76$12,548$648.40+$7.1K → NVRO
3$26,882$5,873.02$14,440$1,013.98+$12.4K → NVRO
4$36,278$7,514.85$17,068$1,617.30+$19.2K → NVRO
5$48,296$9,478.22$20,912$2,649.52+$27.4K → NVRO
6$63,469$11,792.55$26,875$4,499.29+$36.6K → NVRO
7$82,395$14,483.60$36,771$8,014.12+$45.6K → NVRO
8$105,736$17,572.52$54,542$15,197.11+$51.2K → NVRO
9$134,212$21,075.04$89,602$31,242.49+$44.6K → NVRO
10$168,608$25,000.88$167,011$71,136.45+$1.6K → NVRO

NVRO vs SBUX: Complete Analysis 2026

NVRO — Stock

Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.

Full NVRO Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this NVRO vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NVRO vs SCHDNVRO vs JEPINVRO vs ONVRO vs KONVRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.